Ingredients Categories

Product description

The food supplement for the management of persistent HPV infections. One clinical trial demonstrated a clearance of HPV in 85% of patients after 3 months of administration. One case report and one in-vitro study further support safety and efficacy, while there are two ongoing clinical trials.
Read more

Specifications

Categories Specialised Finished ProductsDietary supplements

Specialised Finished ProductsFunctional food

Immune Support

Clinical Trials
Sales markets Western Europe | Eastern Europe | Middle East | Asia | Australia | North America | Africa | Central/South America
Supplied from Italy
Certifications Health & Safety

More products from Lo.Li. Pharma International Srl.

View all our products (15)

Products from other suppliers